Cannabinoids found in hemp: a complete guide
In brief:
- Hemp contains more than 120 cannabinoids, including CBD, THC, CBG, CBN, and CBC, with varying effects. Decarboxylation is essential for activating these molecules, particularly raw CBD. Full Spectrum extracts harness the entourage effect by combining several compounds for enhanced efficacy, with particular attention to CBD/THC ratios.
Hemp (Cannabis sativa L.) contains more than 120 identified cannabinoids, all produced in the plant’s trichomes, those small resin glands that concentrate 80–90% of the active compounds. These molecules, known as phytocannabinoids, interact with the human body’s endocannabinoid system through specific receptors. CBD, THC, CBG, CBN, and CBC are the most studied, but each has a distinct pharmacological profile. Understanding the cannabinoids found in hemp means understanding why two hemp products can produce very different effects.
1. what are the main cannabinoids found in hemp?
Industrial hemp differs from recreational cannabis in its THC content, legally capped at 0.3% in Europe. The cannabinoids found in hemp fall into two categories: major cannabinoids, present in measurable quantities, and minor cannabinoids, active at low concentrations but pharmacologically significant.
Here are the main compounds to know:
- CBD (cannabidiol): the most abundant cannabinoid in industrial hemp. Non-psychoactive, it has anti-inflammatory and anxiolytic properties documented in several clinical studies.
- THC (tetrahydrocannabinol): psychoactive at high doses, but present only in trace amounts in legal hemp. Its acute reference dose in the EU is set at 1 μg/kg of body weight.
- CBG (cannabigerol): nicknamed the “stem cell cannabinoid” because it is the biosynthetic precursor of THC, CBD, and CBC. Its concentration varies according to the plant’s maturity.
- CBN (cannabinol): produced through the degradation of THC, it is associated with sedative effects and potential applications for sleep.
- CBC (cannabichromene): a minor cannabinoid with anti-inflammatory and analgesic potential, still little studied but promising.
An often-overlooked technical point: in the living plant, these molecules exist in acidic form (CBDA, THCA, CBGA). Heat-induced decarboxylation transforms them into active forms. Without this step, the raw CBD in a fresh flower produces a limited pharmacological effect.
Pro tip: Choose extracts that have undergone controlled decarboxylation. A product labeled “CBDA” is not equivalent to a product containing active CBD.
2. how do cannabinoids act on the human body?
The endocannabinoid system is a network of receptors found throughout the body. The two main receptors are CB1, concentrated in the brain and nervous system, and CB2, found more extensively in the immune system. Natural cannabinoids from hemp bind to these receptors or modulate their activity, which explains their wide range of effects.
CBD acts on the nervous system without causing euphoria because it does not directly activate CB1 receptors. It also modulates 5-HT1A and GPR55 receptors, giving it anxiolytic properties. THC, on the other hand, binds directly to CB1 receptors, producing its characteristic psychoactive effect.
A key concept for understanding the effects of cannabinoids is the entourage effect. This synergy between cannabinoids, terpenes, and flavonoids increases the overall effectiveness of an extract compared with an isolated compound. A Full Spectrum product harnesses this natural synergy. A pure CBD isolate, on the other hand, acts alone, without this reinforcement.
The potential therapeutic applications of cannabinoids cover several areas:
- Anxiety and stress: CBD reduces activation of the amygdala, a brain region linked to fear.
- Insomnia: CBN and CBD show encouraging results, according to a meta-analysis of 54 trials involving 2,477 participants.
- Chronic inflammation: CBD and CBC act on inflammatory pathways without the side effects of conventional anti-inflammatory drugs.
- Neurological disorders: CBG has neuroprotective properties currently undergoing clinical evaluation.
This same meta-analysis highlights that the evidence remains generally limited for mental health. The results are promising, but they do not replace medical advice.
3. Full Spectrum, Broad Spectrum, or isolate: what is the difference?
The profile of a hemp extract directly determines its effects. Three main categories structure the European hemp extract market.
| Extract type | Composition | Entourage effect | THC content |
|---|---|---|---|
| Full Spectrum | All cannabinoids + terpenes + flavonoids | Maximum | Legal traces (< 0.3%) |
| Broad Spectrum | Cannabinoids + terpenes, without THC | Partial | Absent |
| CBD isolate | 99%+ pure CBD | Absent | Absent |
Full Spectrum products retain all the plant’s natural compounds. This approach tends to produce greater therapeutic efficacy than pure isolates, thanks to molecular synergy. For people subject to anti-doping tests or sensitive to THC, Broad Spectrum or isolate products remain the safest options.
The CBD:THC ratio also plays a decisive role. A ratio of 2:1 or higher promotes more manageable experiences, as CBD modulates THC’s effects through the 5-HT1A and GPR55 receptors, reducing the anxiety and paranoia that THC can induce at high doses. This is not simple neutralization: it is fine-tuned modulation.
Pro tip: For daily wellness use, a certified-quality Full Spectrum extract offers the best balance of benefits and safety profile. Always check for an independent certificate of analysis (COA).
4. emerging cannabinoids: THCP, CBDV, THCV, and HHC
Research on natural cannabinoids is no longer limited to CBD and THC. Several rare molecules are attracting the attention of researchers and the European market in 2026.
- THCP (tetrahydrocannabiphorol): discovered in 2019, it has a significantly higher affinity for CB1 receptors than THC. Its therapeutic potential is being studied, but its regulatory status remains unclear in most EU countries.
- CBDV (cannabidivarin): a structural analogue of CBD, it is the subject of clinical trials for autism spectrum disorders and epilepsy, notably by GW Pharmaceuticals.
- THCV (tetrahydrocannabivarin): associated with reduced appetite and effects on blood sugar, it is of interest in research on type 2 diabetes.
- HHC (hexahydrocannabinol): a semi-synthetic cannabinoid that appeared widely on the European market starting in 2022. Its sale has been restricted as a precautionary measure since 2023–2024 in several European countries due to an uncertain safety profile.
Caution is warranted with semi-synthetic cannabinoids. Uncertainties about their safety and the quality of current products are real. Unlike CBD or CBG derived directly from hemp, HHC results from a chemical transformation in a laboratory, which complicates quality control and traceability.
Clinical research on minor cannabinoids remains emerging, but it highlights potential for targeted uses that complement existing treatments.
Key points
The cannabinoids found in hemp form a group of more than 120 molecules whose effectiveness depends on their active form, their combination, and the profile of the selected extract.
| Point | Details |
|---|---|
| Molecular diversity | More than 120 cannabinoids have been identified, including CBD, THC, CBG, CBN, and CBC, each with distinct effects. |
| Decarboxylation required | Acidic forms (CBDA, THCA) require thermal activation to produce their effects. |
| Entourage effect | Full Spectrum extracts combine cannabinoids and terpenes for enhanced therapeutic synergy. |
| THC threshold in Europe | The acute reference dose for THC in the EU is set at 1 μg/kg of body weight. |
| Emerging cannabinoids | THCP, CBDV, and THCV are promising, but semi-synthetic HHC is subject to European restrictions. |
What fifteen years of observing the market have taught me about cannabinoids
When I began following the hemp market in Europe, the conversation boiled down to “CBD versus THC.” Today, this simplification seems almost naive to me. The real question is not which cannabinoid to choose, but how they work together.
What most articles do not state clearly: a CBD isolate with 99% purity is not necessarily “better” than a Full Spectrum extract with 40% CBD. Purity is not synonymous with effectiveness. The entourage effect, which I have seen underestimated for years, is now one of the most serious areas of research in hemp pharmacology.
I am also concerned about the enthusiasm surrounding HHC and semi-synthetic cannabinoids. The European market absorbed these products very quickly, often without a clear regulatory framework. The restrictions gradually being introduced in several countries are no surprise. They were predictable. Choosing certified and traceable products is not an excessive precaution. It is the foundation.
Finally, decarboxylation remains the point consumers understand least. Many people buy hemp flowers without knowing that raw, non-decarboxylated CBD produces a very different effect from a processed extract. Understanding this simple chemistry radically changes how these products are used.
— Rod
Find certified hemp products that comply with European standards
Cbd-certified offers a selection of rigorously tested cannabinoid products, with certificates of analysis available for each product. Whether you are looking for Full Spectrum extracts, CBD isolates, or CBG products, every item complies with European legal thresholds and benefits from complete traceability from the plant to the finished product.
Deliveries are available throughout the European Union, the United Kingdom, and Switzerland. Cbd-certified selects only suppliers whose products are tested by independent laboratories. To discover the full range and order with confidence, visit the CBD shop in Europe from Cbd-certified. CBD flower packs are especially popular for exploring the entourage effect at an accessible price.
Frequently asked questions
How many cannabinoids does hemp contain?
Hemp contains more than 120 identified cannabinoids, concentrated mainly in the plant’s trichomes. The most studied are CBD, THC, CBG, CBN, and CBC.
Is CBD psychoactive?
CBD is non-psychoactive: it does not directly activate the CB1 receptors responsible for the euphoria associated with THC. It acts on other receptors, notably 5-HT1A, which explains its anxiolytic effects.
What is the entourage effect?
The entourage effect refers to the synergy between cannabinoids, terpenes, and flavonoids that enhances the overall effectiveness of a hemp extract. Full Spectrum products harness this effect, unlike pure isolates.
Is HHC legal in Europe?
HHC is a semi-synthetic cannabinoid whose sale has been restricted in several European countries since 2023–2024 as a precautionary measure. Its safety profile remains uncertain, and its regulation varies between Member States.
What is the tolerated THC dose in hemp products in Europe?
The acute reference dose for THC set by EFSA is 1 μg/kg of body weight. Legal hemp-based products in Europe contain less than 0.3% THC, which remains within safety limits for the vast majority of consumers.